Holen Sie sich die Stockscreener-App
172.54
3.49%
5.82
Handel nachbörslich:
172.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$166.72
Offen:
$165.55
24-Stunden-Volumen:
1.43M
Relative Volume:
0.79
Marktkapitalisierung:
$20.27B
Einnahmen:
$6.28B
Nettoeinkommen (Verlust:
$703.80M
KGV:
30.39
EPS:
5.6784
Netto-Cashflow:
$1.14B
1W Leistung:
-2.56%
1M Leistung:
+9.47%
6M Leistung:
-17.74%
1J Leistung:
-29.86%
1-Tages-Spanne:
$165.55
$175.94
1-Wochen-Bereich:
$155.00
$181.20
52-Wochen-Spanne:
$150.75
$271.84
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
172.54 | 19.59B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
201.34 | 25.31B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
72.53 | 7.90B | 11.22B | 845.00M | 951.00M | 6.8984 |
FCN
Fti Consulting Inc
|
159.79 | 4.75B | 3.87B | 266.68M | 255.97M | 8.4148 |
HURN
Huron Consulting Group Inc
|
112.30 | 1.77B | 1.75B | 103.75M | 103.64M | 5.8551 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Fortgesetzt | BofA Securities | Buy |
| 2025-10-13 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-01 | Eingeleitet | Seaport Research Partners | Neutral |
| 2025-07-10 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-06-23 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Equifax Inc (EFX) Shares Surge 3.5% -- What GF Score of 75 Tells Investors - GuruFocus
Equifax Q3 Outlook Pressured by Contract Signing Delays, Oppenheimer Says - marketscreener.com
Equifax Launches $1 Billion Senior Notes Offering Featuring Attractive Interest Rates - Kalkine Media
A Quick Look at Today's Ratings for Equifax(EFX.US), With a Forecast Between $179 to $235 - Moomoo
Equifax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Equifax (EFX) Q2 2026 earnings summary - Quartr
Analysts Are Bullish on These Industrial Goods Stocks: Equifax (EFX), Rocket Lab USA (RKLB) - The Globe and Mail
EQUIFAX INC : JP MORGAN CUTS TARGET PRICE TO $210 FROM $230 - Bitget
Equifax Inc Files Pricing Term Sheet For Two-Part Senior Notes Offering Of $1 BillionSEC Filing - TradingView
Equifax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
Is Equifax (EFX) A Bargain As New Debt Clouds Its Valuation? - Yahoo Finance
Is Equifax’s Q2 Results and Círculo de Crédito Deal Altering The Investment Case For Equifax (EFX)? - Sahm
Equifax Says Inflation Is Hitting Lower-Income Consumers - Sahm
EFX Maintained by Morgan Stanley -- Price Target Lowered to $225 - GuruFocus
EFX Maintains by Baird -- Price Target Lowered to $232 - GuruFocus
Deutsche Bank Adjusts Equifax Price Target to $208 From $217, Maintains Buy Rating - Moomoo
EFX Maintains by RBC Capital -- Price Target Lowered to $194.00 - GuruFocus
Morgan Stanley Adjusts Price Target on Equifax to $225 From $243, Maintains Overweight Rating - Moomoo
Barclays Adjusts Price Target on Equifax to $200 From $215, Maintains Equalweight Rating - Moomoo
JPMorgan Adjusts Equifax Price Target to $210 From $230 - Moomoo
Wells Fargo Adjusts Price Target on Equifax to $212 From $220, Maintains Overweight Rating - Moomoo
These Analysts Slash Their Forecasts On Equifax After Q2 Results - Benzinga
BNP Paribas Adjusts Price Target on Equifax to $190 From $185, Maintains Neutral Rating - Moomoo
Needham Adjusts Price Target on Equifax to $245 From $265, Maintains Buy Rating - marketscreener.com
Needham lowers Equifax stock price target to $245 on guidance - Investing.com
Needham lowers Equifax stock price target to $245 on guidance By Investing.com - Investing.com Canada
Equifax, Inc. (EFX) Stock Forecasts - Yahoo Finance
EQUIFAX INC : NEEDHAM CUTS TARGET PRICE TO $245 FROM $265 - Bitget
RBC Cuts Price Target on Equifax to $194 From $222, Keeps Outperform Rating - marketscreener.com
Baird Adjusts Price Target on Equifax to $232 From $245, Maintains Outperform Rating - Moomoo
Goldman Sachs Adjusts Price Target on Equifax to $182 From $173, Maintains Neutral Rating - marketscreener.com
Equifax Inc at Goldman Sachs U.S. Financial Services Conference Transcript - GuruFocus
Q3 2025 Equifax Inc Earnings Call Transcript - GuruFocus
Equifax (EFX) Reports Q2 Earnings, Misses EPS Expectations - GuruFocus
Q4 2025 Equifax Inc Earnings Call Transcript - GuruFocus
RBC Capital cuts Equifax stock price target on GenAI concerns - Investing.com
RBC Capital cuts Equifax stock price target on GenAI concerns By Investing.com - Investing.com Canada
Equifax Work Number by Equifax Inc.employment data as a growth engine - Ad-hoc-news.de
Equifax (EFX) Stock May Be Above Fair Value Despite The $750M Credit Bureau Deal - Yahoo Finance
EFX SWOT Analysis: Financial Resilience Amidst Economic Uncertai - GuruFocus
Equifax (EFX) Proxy Filing Summary - Quartr
Equifax’s AI Savings, Buybacks and Mexico Deal Could Be A Game Changer For Equifax (EFX) - Yahoo Finance
A Look at Equifax Inc (EFX) After 3.9% Decline -- GF Value $289. - GuruFocus
Equifax (EFX) Reports Q2 Earnings Miss, Shares Drop 7% - GuruFocus
Equifax, Inc. Stock 12‑Month Price Target Cut to $216.09, Implies 20% Upside - TradingView
Equifax (EFX) Q2 2026 Deep Dive: $2.25 EPS, Revenue Up 11% - AlphaStreet
Equifax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Equifax Inc (EFX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Equifax Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Equifax (EFX) Raises Revenue Outlook and Highlights Strong Q2 Pe - GuruFocus
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):